Search research articles
Contact Us
Filters
Showing results (211-220 of 255) with videos related to
Page
of 26
Sort By:
Progress in Clinical and Biological Research
|
January 1, 1990
The value of the bone scan
P H Smith, F Debruyne, T G Armitage, et al.
British Journal of Urology
|
January 1, 1976
Treatment of advanced bladder cancer with adriamycin and 5-fluorouracil
R J Cross, R W Glashan, C S Humphrey, et al.
Clinical Chemistry
|
July 1, 1982
Clinical significance of serum acid phosphatase as measured by ELISA after treatment of benign prostatic hyperplasia
E H Cooper, N B Pidcock, R Glashan, et al.
Acta Urologica Belgica
|
January 1, 1980
Hormone therapy in prostatic cancer
P H Smith, A Akdas, M K Mason, et al.
Science (New York, N.Y.)
|
February 23, 1979
Preliminary results of the solar flux radiometer experiment aboard the pioneer venus multiprobe mission
M G Tomasko, L R Doose, J Palmer, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
January 1, 1978
Stimulation by gastric inhibitory polypeptide of insulin and glucagon secretion by rat islet cultures
W Y Fujimoto, J W Ensinck, F W Merchant, et al.
Lancet (London, England)
|
March 26, 1988
Post-Chernobyl radiocaesium exposure in the UK
K Boddy, J D Fenwick, A L McKenzie, et al.
European Urology
|
March 31, 1998
Maximal androgen blockade: final analysis of EORTC phase III trial 30853. EORTC Genito-Urinary Tract Cancer Cooperative Group and the EORTC Data Center
L J Denis, F Keuppens, P H Smith, et al.
European Urology
|
January 1, 1995
Tryptophan metabolites, pyridoxine (vitamin B6) and their influence on the recurrence rate of superficial bladder cancer. Results of a prospective, randomised phase III study performed by the EORTC GU Group. EORTC Genito-Urinary Tract Cancer Cooperative Group
D W Newling, M R Robinson, P H Smith, et al.
Cancer
|
September 1, 1990
Some limitations of the radioisotope bone scan in patients with metastatic prostatic cancer. A subanalysis of EORTC trial 30853. The EORTC Urological Group
P H Smith, A Bono, F Calais da Silva, et al.
Page
of 26
Search research articles
Search
Showing results (211-220 of 255) with videos related to
Sort By:
Page
of 26
Progress in Clinical and Biological Research
|
January 1, 1990
The value of the bone scan
P H Smith, F Debruyne, T G Armitage, et al.
British Journal of Urology
|
January 1, 1976
Treatment of advanced bladder cancer with adriamycin and 5-fluorouracil
R J Cross, R W Glashan, C S Humphrey, et al.
Clinical Chemistry
|
July 1, 1982
Clinical significance of serum acid phosphatase as measured by ELISA after treatment of benign prostatic hyperplasia
E H Cooper, N B Pidcock, R Glashan, et al.
Acta Urologica Belgica
|
January 1, 1980
Hormone therapy in prostatic cancer
P H Smith, A Akdas, M K Mason, et al.
Science (New York, N.Y.)
|
February 23, 1979
Preliminary results of the solar flux radiometer experiment aboard the pioneer venus multiprobe mission
M G Tomasko, L R Doose, J Palmer, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
January 1, 1978
Stimulation by gastric inhibitory polypeptide of insulin and glucagon secretion by rat islet cultures
W Y Fujimoto, J W Ensinck, F W Merchant, et al.
Lancet (London, England)
|
March 26, 1988
Post-Chernobyl radiocaesium exposure in the UK
K Boddy, J D Fenwick, A L McKenzie, et al.
European Urology
|
March 31, 1998
Maximal androgen blockade: final analysis of EORTC phase III trial 30853. EORTC Genito-Urinary Tract Cancer Cooperative Group and the EORTC Data Center
L J Denis, F Keuppens, P H Smith, et al.
European Urology
|
January 1, 1995
Tryptophan metabolites, pyridoxine (vitamin B6) and their influence on the recurrence rate of superficial bladder cancer. Results of a prospective, randomised phase III study performed by the EORTC GU Group. EORTC Genito-Urinary Tract Cancer Cooperative Group
D W Newling, M R Robinson, P H Smith, et al.
Cancer
|
September 1, 1990
Some limitations of the radioisotope bone scan in patients with metastatic prostatic cancer. A subanalysis of EORTC trial 30853. The EORTC Urological Group
P H Smith, A Bono, F Calais da Silva, et al.
Page
of 26